ISSN: 2044-9038 (Print) 2044-9046 (Electronic)

Clinical Practice

Hepatic Adenoma Peer-review Journals

 Hepatic adenoma is understood as a benign lesion encountered mainly in female patients and classically linked to the administration of oral contraceptives. In the last decade, the risk factors for its occurrence have changed and so did the sex ratio. The histopathological classification of hepatic adenomas was found to be related with certain genetic mutations that determine the danger for malignancy. The diagnosis of hepatic tumor is correlated with clinical and imaging data in an attempt not only to rule out other tumors but also to differentiate the subtype of adenoma, which is extremely important for the management of the patient. The ultimate diagnosis is established by pathologists by routine histopathological and specific immunohistochemical staining. There are two major issues that pathologists need to recognize: the presence of β-catenin gene mutation and/or malignant degeneration. Hepatic adenoma is generally identified by imaging, regularly a ultrasound or CT, as a hyperenhancing liver knob. Given that few liver tumors show up also on these imaging modalities, a multi-stage differentiate improved imaging study, for example, CT or MRI might be utilized to give more data. The hugeness of making a particular finding is that, not normal for other generous liver tumors, for example, hemangioma and central nodular hyperplasia, hepatic adenomas have a little yet significant danger of advancing into a malignancy. Although imaging gives strong data, an authoritative determination of hepatic adenoma requires biopsy of the tissue.    

High Impact List of Articles

Relevant Topics in Clinical